Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its U.S. teams back to the nest with a new expansion in the Blue Hen State.